Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.19 trillion and total revenue of $110.17 billion.
Market Cap
1.19T
Revenue
110.17B
Profits
-39.86B
PE Ratio
n/a
Profit Margin
-36.19%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.71B | -0.46% | 789,396 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.90B | -0.15% | 493,843 | 14.34B |
| 3 | ARGX | argenx SE | 51.85B | -1.72% | 217,784 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.24B | 0.41% | 966,502 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 35.27B | -1.79% | 155,006 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.83B | -1.15% | 1,070,999 | 606.42M |
| 7 | RVMD | Revolution Medicines, Inc. | 30.76B | -1.61% | 3,495,317 | - |
| 8 | RPRX | Royalty Pharma plc | 29.23B | -1.40% | 2,524,274 | 2.38B |
| 9 | BNTX | BioNTech SE | 26.60B | 2.21% | 908,028 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 21.65B | 1.62% | 5,440,186 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.81B | -2.51% | 4,748,377 | 13.31M |
| 12 | SMMT | Summit Therapeutics Inc. | 19.48B | -0.12% | 3,371,461 | - |
| 13 | INCY | Incyte Corporation | 19.29B | -0.92% | 1,033,224 | 5.14B |
| 14 | GMAB | Genmab A/S | 17.18B | -2.24% | 1,810,435 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 15.16B | 0.37% | 403,350 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.87B | -0.09% | 1,650,391 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.47B | -0.42% | 777,759 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.37B | -1.11% | 1,106,829 | 943.71M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.09B | -0.92% | 292,704 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.33B | -2.85% | 2,045,473 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.55B | 0.44% | 1,598,443 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.70B | -0.37% | 1,198,670 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.65B | -0.16% | 525,007 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.54B | 0.02% | 328,398 | 7.46M |
| 25 | TECH | Bio-Techne Corporation | 9.48B | 2.28% | 2,012,328 | 1.22B |
| 26 | ABVX | ABIVAX Société Anonyme | 9.39B | -4.31% | 867,647 | 5.37M |
| 27 | PCVX | Vaxcyte, Inc. | 8.92B | -0.58% | 945,814 | - |
| 28 | NUVL | Nuvalent, Inc. | 8.51B | 0.59% | 392,548 | - |
| 29 | IBRX | ImmunityBio, Inc. | 8.47B | 6.49% | 16,210,550 | 113.29M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.24B | 0.40% | 1,203,154 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 8.15B | -0.85% | 1,027,494 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 8.14B | 0.84% | 210,388 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.10B | -0.89% | 375,402 | 39.21M |
| 34 | ERAS | Erasca, Inc. | 6.75B | 14.20% | 7,627,144 | - |
| 35 | ACLX | Arcellx, Inc. | 6.75B | -0.04% | 726,511 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.73B | -0.48% | 540,470 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.71B | -1.39% | 483,212 | - |
| 38 | BLTE | Belite Bio, Inc | 6.51B | -0.01% | 79,177 | - |
| 39 | SYRE | Spyre Therapeutics, Inc. | 6.33B | 0.52% | 915,910 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.38% | 1,690,543 | 15.00M |
| 41 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.17% | 4,152,864 | - |
| 42 | CAI | Caris Life Sciences, Inc. | 6.00B | 0.43% | 1,564,363 | 812.03M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.99B | -1.09% | 596,766 | 189.76M |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.99B | -0.15% | 956,853 | 1.73B |
| 45 | COGT | Cogent Biosciences, Inc. | 5.96B | -0.67% | 1,160,322 | - |
| 46 | CGON | CG Oncology, Inc. | 5.94B | -4.13% | 930,500 | 4.04M |
| 47 | IMVT | Immunovant, Inc. | 5.81B | -2.63% | 1,501,531 | - |
| 48 | CELC | Celcuity Inc. | 5.80B | -1.94% | 937,098 | - |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.78B | -2.29% | 564,521 | 521.31M |
| 50 | CRSP | CRISPR Therapeutics AG | 5.54B | -0.52% | 1,263,497 | 3.51M |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.49B | -4.32% | 1,128,835 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 5.46B | 4.61% | 2,481,549 | 616.29M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.45B | -4.37% | 1,120,932 | 7.50M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.10% | 4,108,076 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 5.00B | -1.44% | 534,819 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.93B | 0.39% | 722,709 | 761.41M |
| 57 | LEGN | Legend Biotech Corporation | 4.64B | 18.42% | 7,406,525 | 1.03B |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.62B | -0.02% | 112,744 | 268.09M |
| 59 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 1,654,945 | 634.21M |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.21B | -1.83% | 1,189,078 | 7.70M |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.12B | 0.94% | 1,827,744 | - |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | -2.48% | 417,291 | 22.50M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -0.36% | 1,037,485 | 1.07B |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.77B | -0.94% | 1,515,979 | 62.38M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.72B | -1.18% | 1,448,579 | 490.73M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.64B | -1.34% | 617,375 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.52B | -0.09% | 189,377 | 803.79M |
| 68 | GPCR | Structure Therapeutics Inc. | 3.42B | -4.99% | 815,771 | - |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.41B | -0.07% | 1,333,381 | - |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.31B | -1.91% | 1,741,120 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.26B | -0.15% | 738,986 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.18B | -0.72% | 1,545,922 | 588.99M |
| 73 | ALMS | Alumis Inc. | 3.14B | -1.12% | 821,390 | 24.05M |
| 74 | BEAM | Beam Therapeutics Inc. | 3.10B | -0.64% | 1,257,638 | 139.74M |
| 75 | KLRA | Kailera Therapeutics, Inc. | 3.04B | -5.35% | 1,340,999 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.04B | -0.24% | 887,355 | 376.07M |
| 77 | VERA | Vera Therapeutics, Inc. | 2.98B | -1.63% | 755,117 | - |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.95B | -0.91% | 843,919 | 218.71M |
| 79 | RLAY | Relay Therapeutics, Inc. | 2.93B | -2.15% | 2,641,886 | 15.36M |
| 80 | NKTR | Nektar Therapeutics | 2.88B | 18.25% | 4,749,923 | 55.23M |
| 81 | KOD | Kodiak Sciences Inc. | 2.87B | 3.43% | 679,202 | - |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.85B | -6.23% | 2,045,705 | 247.00M |
| 83 | ZLAB | Zai Lab Limited | 2.84B | 4.38% | 1,033,918 | 460.16M |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.81B | -1.89% | 418,517 | 451.36M |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.78B | -3.53% | 492,378 | - |
| 86 | MANE | Veradermics, Incorporated | 2.76B | -3.04% | 257,831 | - |
| 87 | IMNM | Immunome, Inc. | 2.74B | -1.54% | 985,411 | 6.94M |
| 88 | IRON | Disc Medicine, Inc. | 2.73B | -0.50% | 345,021 | - |
| 89 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.21% | 3,197,014 | 190.41M |
| 90 | CLDX | Celldex Therapeutics, Inc. | 2.70B | -0.49% | 943,326 | 1.55M |
| 91 | ADMA | ADMA Biologics, Inc. | 2.53B | -1.18% | 4,935,994 | 510.17M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | -1.67% | 558,593 | - |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.46B | 1.01% | 1,447,588 | 673.00M |
| 94 | AAPG | Ascentage Pharma Group International | 2.42B | -3.80% | 1,928 | 82.08M |
| 95 | DFTX | Definium Therapeutics, Inc. | 2.31B | 2.20% | 5,987,891 | - |
| 96 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | -0.60% | 2,806,819 | 2.20B |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.25B | 0.76% | 1,432,394 | 276.98M |
| 98 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 1,604,992 | 158.18M |
| 99 | TRVI | Trevi Therapeutics, Inc. | 2.16B | 1.12% | 3,871,105 | - |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.16B | -2.17% | 746,023 | 184.42M |
| 101 | MESO | Mesoblast Limited | 2.13B | 0.91% | 216,243 | 65.38M |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -0.56% | 842,919 | 283.06M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 2.10B | -1.86% | 859,613 | 172.35M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 2.07B | -3.05% | 3,386,134 | 51.95M |
| 105 | ZYME | Zymeworks Inc. | 2.05B | 0.18% | 311,827 | 105.97M |
| 106 | CAPR | Capricor Therapeutics, Inc. | 1.98B | -1.41% | 1,038,074 | 11.13M |
| 107 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | -2.38% | 9,829,208 | 74.68M |
| 108 | GLPG | Galapagos NV | 1.93B | - | 67,771 | 1.31B |
| 109 | SION | Sionna Therapeutics, Inc. | 1.92B | -2.07% | 447,998 | - |
| 110 | PHVS | Pharvaris N.V. | 1.89B | 1.36% | 178,993 | - |
| 111 | TSHA | Taysha Gene Therapies, Inc. | 1.86B | 0.47% | 3,058,382 | 9.77M |
| 112 | TYRA | Tyra Biosciences, Inc. | 1.85B | -3.35% | 1,290,785 | - |
| 113 | PVLA | Palvella Therapeutics, Inc. | 1.85B | -0.52% | 170,233 | - |
| 114 | VCEL | Vericel Corporation | 1.82B | 0.36% | 439,892 | 276.26M |
| 115 | NTLA | Intellia Therapeutics, Inc. | 1.80B | 1.74% | 2,578,935 | 67.67M |
| 116 | ATAI | AtaiBeckley Inc. | 1.79B | 21.59% | 47,137,721 | 4.09M |
| 117 | NUVB | Nuvation Bio Inc. | 1.78B | 0.79% | 3,795,048 | 62.90M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.78B | -6.47% | 242,162 | - |
| 119 | VIR | Vir Biotechnology, Inc. | 1.77B | 3.16% | 2,595,660 | 68.56M |
| 120 | INVA | Innoviva, Inc. | 1.77B | -1.32% | 590,035 | 411.33M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.76B | -2.68% | 577,650 | 71.78M |
| 122 | HRMY | Harmony Biosciences Holdings, Inc. | 1.71B | -1.53% | 724,847 | 868.45M |
| 123 | OCS | Oculis Holding AG | 1.69B | 4.19% | 619,579 | 1.51M |
| 124 | BHVN | Biohaven Ltd. | 1.63B | -1.46% | 1,623,606 | - |
| 125 | MBX | MBX Biosciences, Inc. | 1.60B | 0.03% | 503,304 | - |
| 126 | IMCR | Immunocore Holdings plc | 1.59B | 0.03% | 648,725 | 400.02M |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.59B | -0.64% | 205,410 | - |
| 128 | AGIO | Agios Pharmaceuticals, Inc. | 1.59B | -22.97% | 5,823,329 | 54.03M |
| 129 | NBTX | Nanobiotix S.A. | 1.59B | -5.56% | 82,706 | 38.27M |
| 130 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | 0.15% | 1,439,588 | 123.67M |
| 131 | IOVA | Iovance Biotherapeutics, Inc. | 1.56B | -2.07% | 9,751,118 | 263.50M |
| 132 | ARDX | Ardelyx, Inc. | 1.55B | -2.33% | 3,076,288 | 407.32M |
| 133 | GENB | Generate Biomedicines, Inc. | 1.54B | -2.65% | 447,245 | 31.89M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.54B | -2.25% | 353,574 | - |
| 135 | IMTX | Immatics N.V. | 1.51B | 0.72% | 288,997 | 56.67M |
| 136 | VRDN | Viridian Therapeutics, Inc. | 1.50B | -0.81% | 1,694,765 | 70.85M |
| 137 | ANAB | AnaptysBio, Inc. | 1.46B | -24.53% | 1,118,086 | 234.60M |
| 138 | WVE | Wave Life Sciences Ltd. | 1.46B | 1.20% | 3,796,391 | 42.73M |
| 139 | PGEN | Precigen, Inc. | 1.45B | 3.27% | 3,670,957 | 9.68M |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | -1.43% | 1,155,446 | - |
| 141 | SVRA | Savara Inc. | 1.42B | -2.94% | 944,643 | - |
| 142 | NVAX | Novavax, Inc. | 1.41B | -1.92% | 2,761,315 | 1.12B |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.39B | 5.90% | 622,235 | - |
| 144 | MAZE | Maze Therapeutics, Inc. | 1.33B | -4.45% | 521,715 | 2.50M |
| 145 | GHRS | GH Research PLC | 1.33B | 17.23% | 1,454,024 | - |
| 146 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | -7.17% | 1,246,864 | - |
| 147 | MLTX | MoonLake Immunotherapeutics | 1.28B | -2.45% | 557,858 | - |
| 148 | EYPT | EyePoint, Inc. | 1.26B | 0.94% | 803,381 | 31.37M |
| 149 | MPLT | MapLight Therapeutics, Inc. | 1.25B | -5.69% | 274,047 | - |
| 150 | DBVT | DBV Technologies S.A. | 1.25B | -1.59% | 293,656 | 5.64M |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.24B | -4.22% | 299,604 | 10.00M |
| 152 | PHAR | Pharming Group N.V. | 1.24B | 1.33% | 10,936 | 376.13M |
| 153 | URGN | UroGen Pharma Ltd. | 1.21B | 10.56% | 1,276,071 | 109.79M |
| 154 | SEPN | Septerna, Inc. | 1.21B | 2.79% | 654,628 | 45.95M |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -6.62% | 242,350 | 1.30M |
| 156 | ABCL | AbCellera Biologics Inc. | 1.19B | -2.49% | 5,224,816 | 75.13M |
| 157 | IVA | Inventiva S.A. | 1.17B | -1.41% | 219,601 | 7.94M |
| 158 | JBIO | Jade Biosciences, Inc. | 1.16B | 2.84% | 532,251 | - |
| 159 | AKTS | Aktis Oncology, Inc. | 1.15B | 2.86% | 196,144 | 6.50M |
| 160 | QURE | uniQure N.V. | 1.14B | 2.62% | 2,221,804 | 16.10M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | 1.30% | 1,195,208 | - |
| 162 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -1.88% | 1,491,487 | 291.85M |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 1.07B | 2.12% | 762,644 | 175.11M |
| 164 | KALV | KalVista Pharmaceuticals, Inc. | 1.07B | 1.90% | 703,055 | 73.62M |
| 165 | CTMX | CytomX Therapeutics, Inc. | 1.06B | 1.45% | 3,210,965 | 76.20M |
| 166 | SANA | Sana Biotechnology, Inc. | 1.05B | 8.52% | 5,264,696 | - |
| 167 | ANNX | Annexon, Inc. | 1.03B | -1.68% | 1,429,295 | - |
| 168 | EVMN | Evommune, Inc. | 1.01B | 1.89% | 347,819 | 13.00M |
| 169 | GERN | Geron Corporation | 999.80M | -7.14% | 21,052,061 | 183.88M |
| 170 | FTRE | Fortrea Holdings Inc. | 976.14M | 0.58% | 590,146 | 2.72B |
| 171 | CMPX | Compass Therapeutics, Inc. | 975.18M | -9.75% | 2,761,918 | 850.00K |
| 172 | MGTX | MeiraGTx Holdings plc | 974.63M | 4.05% | 1,453,831 | 81.39M |
| 173 | OMER | Omeros Corporation | 969.79M | 0.22% | 1,103,034 | - |
| 174 | JANX | Janux Therapeutics, Inc. | 965.40M | 0.32% | 2,506,758 | 10.00M |
| 175 | ANRO | Alto Neuroscience, Inc. | 957.99M | -1.41% | 334,880 | - |
| 176 | XNCR | Xencor, Inc. | 938.73M | -1.99% | 643,723 | 125.58M |
| 177 | MRVI | Maravai LifeSciences Holdings, Inc. | 928.01M | 6.49% | 2,494,519 | 185.74M |
| 178 | LBRX | LB Pharmaceuticals Inc | 908.13M | 3.77% | 208,549 | - |
| 179 | ABUS | Arbutus Biopharma Corporation | 905.92M | -2.54% | 874,100 | 14.08M |
| 180 | MNKD | MannKind Corporation | 901.68M | 2.82% | 3,877,651 | 348.97M |
| 181 | SLS | SELLAS Life Sciences Group, Inc. | 896.12M | -4.41% | 6,420,421 | - |
| 182 | DRUG | Bright Minds Biosciences Inc. | 882.87M | 0.99% | 77,156 | - |
| 183 | CGEM | Cullinan Therapeutics, Inc. | 878.84M | -3.59% | 645,373 | - |
| 184 | KURA | Kura Oncology, Inc. | 868.10M | 1.03% | 1,605,723 | 67.48M |
| 185 | TBPH | Theravance Biopharma, Inc. | 860.96M | -2.96% | 471,522 | 107.46M |
| 186 | VOR | Vor Biopharma Inc. | 851.26M | -5.30% | 1,086,775 | - |
| 187 | FBRX | Forte Biosciences, Inc. | 842.79M | 1.50% | 178,435 | - |
| 188 | SLDB | Solid Biosciences Inc. | 835.37M | -1.62% | 877,944 | - |
| 189 | ALLO | Allogene Therapeutics, Inc. | 832.43M | 1.26% | 12,063,720 | 22.00K |
| 190 | SGP | SpyGlass Pharma, Inc. | 819.62M | -1.68% | 23,088 | - |
| 191 | SPRY | ARS Pharmaceuticals, Inc. | 812.25M | - | 965,330 | 84.28M |
| 192 | DSGN | Design Therapeutics, Inc. | 811.61M | 0.30% | 152,780 | - |
| 193 | LXRX | Lexicon Pharmaceuticals, Inc. | 779.57M | -1.60% | 1,608,634 | 49.80M |
| 194 | RLMD | Relmada Therapeutics, Inc. | 773.03M | -1.47% | 2,201,232 | - |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 741.10M | -0.96% | 872,945 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 725.03M | -1.98% | 50,627 | 116.59M |
| 197 | CBIO | Crescent Biopharma, Inc. | 720.41M | 1.93% | 162,023 | 10.84M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 713.76M | 1.00% | 247,999 | - |
| 199 | TENX | Tenax Therapeutics, Inc. | 709.24M | -2.42% | 521,586 | - |
| 200 | ARVN | Arvinas, Inc. | 691.42M | -1.73% | 540,348 | 262.60M |
| 201 | PRME | Prime Medicine, Inc. | 688.84M | 2.10% | 1,064,907 | 4.63M |
| 202 | KYTX | Kyverna Therapeutics, Inc. | 680.97M | 13.29% | 2,650,821 | - |
| 203 | ANL | Adlai Nortye Ltd. | 664.00M | 3.69% | 847,049 | 5.00M |
| 204 | PROK | ProKidney Corp. | 634.02M | -3.67% | 657,956 | 893.00K |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 632.91M | 1.03% | 633,028 | 106.47M |
| 206 | EIKN | Eikon Therapeutics, Inc. | 625.30M | -2.94% | 163,076 | - |
| 207 | OCGN | Ocugen, Inc. | 625.11M | -7.04% | 11,316,996 | 4.41M |
| 208 | ABSI | Absci Corporation | 604.43M | 10.34% | 5,774,586 | 2.80M |
| 209 | RIGL | Rigel Pharmaceuticals, Inc. | 600.19M | 0.19% | 235,713 | 294.28M |
| 210 | CRMD | CorMedix Inc. | 599.20M | 2.57% | 1,043,090 | 311.71M |
| 211 | STTK | Shattuck Labs, Inc. | 595.58M | 4.65% | 1,013,030 | 1.00M |
| 212 | ACRS | Aclaris Therapeutics, Inc. | 590.73M | - | 1,076,021 | 7.83M |
| 213 | PRTA | Prothena Corporation plc | 580.86M | -1.01% | 333,299 | 9.68M |
| 214 | LYEL | Lyell Immunopharma, Inc. | 580.64M | 3.67% | 123,879 | 36.00K |
| 215 | STRO | Sutro Biopharma, Inc. | 572.90M | 9.60% | 201,849 | 102.48M |
| 216 | VSTM | Verastem, Inc. | 572.74M | -0.91% | 1,954,399 | 30.91M |
| 217 | ENGN | enGene Therapeutics Inc. | 571.42M | 5.70% | 395,742 | - |
| 218 | UPB | Upstream Bio, Inc. | 543.66M | - | 387,892 | 2.85M |
| 219 | TECX | Tectonic Therapeutic, Inc. | 540.02M | -2.54% | 219,830 | - |
| 220 | ADCT | ADC Therapeutics SA | 539.94M | -0.70% | 844,332 | 81.36M |
| 221 | VALN | Valneva SE | 535.43M | 1.34% | 260,650 | 205.07M |
| 222 | IMMX | Immix Biopharma, Inc. | 534.89M | -2.51% | 568,433 | - |
| 223 | CADL | Candel Therapeutics, Inc. | 528.84M | 13.34% | 5,301,238 | - |
| 224 | FULC | Fulcrum Therapeutics, Inc. | 528.81M | -4.22% | 727,026 | 80.00M |
| 225 | AGMB | AgomAb Therapeutics NV | 525.87M | -4.77% | 351,180 | - |
| 226 | FDMT | 4D Molecular Therapeutics, Inc. | 514.09M | -4.00% | 473,091 | 85.21M |
| 227 | ZURA | Zura Bio Limited | 509.51M | -7.57% | 1,032,860 | - |
| 228 | CTNM | Contineum Therapeutics, Inc. | 502.92M | -0.44% | 327,194 | - |
| 229 | LRMR | Larimar Therapeutics, Inc. | 499.68M | 0.21% | 862,710 | - |
| 230 | RGNX | REGENXBIO Inc. | 488.82M | -0.21% | 656,228 | 170.44M |
| 231 | TRDA | Entrada Therapeutics, Inc. | 488.16M | -3.07% | 134,091 | 25.42M |
| 232 | LXEO | Lexeo Therapeutics, Inc. | 483.79M | -5.50% | 787,914 | - |
| 233 | MDXG | MiMedx Group, Inc. | 482.84M | -4.83% | 2,523,104 | 418.63M |
| 234 | BNTC | Benitec Biopharma Inc. | 479.23M | -0.64% | 85,238 | - |
| 235 | XOMA | XOMA Royalty Corporation | 476.63M | 0.73% | 110,055 | 52.15M |
| 236 | IVVD | Invivyd, Inc. | 475.11M | -3.45% | 1,602,250 | 53.43M |
| 237 | VTVT | vTv Therapeutics Inc. | 468.46M | -0.97% | 27,897 | 17.00K |
| 238 | DNA | Ginkgo Bioworks Holdings, Inc. | 464.49M | -0.62% | 944,933 | 170.16M |
| 239 | ALT | Altimmune, Inc. | 463.17M | 1.71% | 2,161,683 | 41.00K |
| 240 | ARMP | Armata Pharmaceuticals, Inc. | 457.91M | 8.70% | 82,495 | 4.90M |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 454.93M | -0.52% | 216,269 | - |
| 242 | AURA | Aura Biosciences, Inc. | 452.26M | -3.29% | 327,389 | - |
| 243 | ASMB | Assembly Biosciences, Inc. | 446.22M | -3.80% | 96,693 | 72.30M |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 446.04M | 1.41% | 156,270 | - |
| 245 | PRTC | PureTech Health plc | 436.98M | 0.33% | 978 | 6.39M |
| 246 | NGNE | Neurogene Inc. | 432.03M | -0.39% | 173,978 | 925.00K |
| 247 | CLYM | Climb Bio, Inc. | 428.48M | -2.07% | 598,156 | - |
| 248 | RCKT | Rocket Pharmaceuticals, Inc. | 421.21M | -1.28% | 1,751,851 | - |
| 249 | IPSC | Century Therapeutics, Inc. | 420.55M | -10.00% | 1,135,547 | 109.16M |
| 250 | AUTL | Autolus Therapeutics plc | 420.51M | -1.25% | 887,482 | 75.39M |
| 251 | PALI | Palisade Bio, Inc. | 418.55M | 4.17% | 3,621,149 | - |
| 252 | VNDA | Vanda Pharmaceuticals Inc. | 413.17M | -3.85% | 1,201,950 | 216.11M |
| 253 | LCTX | Lineage Cell Therapeutics, Inc. | 410.99M | -3.51% | 877,071 | 14.56M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 399.89M | -1.64% | 101,577 | 66.98M |
| 255 | NMRA | Neumora Therapeutics, Inc. | 398.67M | 1.86% | 1,891,432 | - |
| 256 | IRD | Opus Genetics, Inc. | 394.17M | -3.65% | 1,143,857 | 14.20M |
| 257 | AVTX | Avalo Therapeutics, Inc. | 391.63M | 1.59% | 600,809 | 59.00K |
| 258 | NAGE | Niagen Bioscience, Inc. | 390.81M | 0.62% | 416,080 | 129.42M |
| 259 | OVID | Ovid Therapeutics Inc. | 381.12M | -0.69% | 2,584,819 | 7.25M |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 380.95M | -2.33% | 215,562 | 35.11M |
| 261 | PBYI | Puma Biotechnology, Inc. | 374.96M | -1.34% | 217,532 | 228.37M |
| 262 | NAUT | Nautilus Biotechnology, Inc. | 374.63M | -2.31% | 148,092 | - |
| 263 | SLN | Silence Therapeutics plc | 374.57M | 5.31% | 227,809 | 559.00K |
| 264 | YDES | YD Bio Limited | 373.40M | -2.39% | 77,278 | 510.36K |
| 265 | PRLD | Prelude Therapeutics Incorporated | 372.23M | 1.58% | 982,448 | 12.14M |
| 266 | SRZN | Surrozen, Inc. | 370.45M | 2.19% | 97,304 | 3.48M |
| 267 | BCYC | Bicycle Therapeutics plc | 368.75M | -0.75% | 213,379 | 72.59M |
| 268 | CABA | Cabaletta Bio, Inc. | 367.92M | -3.92% | 2,110,595 | - |
| 269 | MNPR | Monopar Therapeutics Inc. | 366.06M | -2.70% | 181,670 | - |
| 270 | IMRX | Immuneering Corporation | 357.53M | -0.54% | 712,577 | - |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 353.47M | -4.23% | 161,992 | - |
| 272 | RZLT | Rezolute, Inc. | 350.05M | -2.60% | 1,588,520 | - |
| 273 | EDIT | Editas Medicine, Inc. | 349.40M | 2.29% | 1,831,075 | 40.52M |
| 274 | GLSI | Greenwich LifeSciences, Inc. | 339.71M | -11.61% | 337,603 | - |
| 275 | AVXL | Anavex Life Sciences Corp. | 338.25M | 0.27% | 1,138,039 | - |
| 276 | ARTV | Artiva Biotherapeutics, Inc. | 330.96M | 6.69% | 661,307 | 251.00K |
| 277 | NGEN | NervGen Pharma Corp. | 323.72M | -1.72% | 150,446 | - |
| 278 | FHTX | Foghorn Therapeutics Inc. | 323.44M | 4.16% | 126,944 | 30.91M |
| 279 | LENZ | LENZ Therapeutics, Inc. | 317.62M | -0.49% | 539,801 | 19.09M |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 314.50M | 4.02% | 2,308,208 | - |
| 281 | ABEO | Abeona Therapeutics Inc. | 312.63M | -0.36% | 703,923 | 5.82M |
| 282 | IKT | Inhibikase Therapeutics, Inc. | 308.46M | -1.09% | 1,831,988 | 1.00 |
| 283 | CHRS | Coherus Oncology, Inc. | 306.89M | 0.51% | 764,204 | 42.17M |
| 284 | NBP | NovaBridge Biosciences | 306.47M | -1.85% | 319,219 | - |
| 285 | NERV | Minerva Neurosciences, Inc. | 302.07M | 2.38% | 241,223 | - |
| 286 | CLLS | Cellectis S.A. | 299.57M | -7.24% | 25,739 | 79.59M |
| 287 | ALEC | Alector, Inc. | 298.53M | 5.25% | 324,864 | 21.05M |
| 288 | ACIU | AC Immune SA | 295.62M | -1.00% | 200,142 | 4.51M |
| 289 | CCCC | C4 Therapeutics, Inc. | 291.76M | 2.40% | 2,573,788 | 35.95M |
| 290 | TARA | Protara Therapeutics, Inc. | 286.65M | -2.57% | 394,962 | - |
| 291 | ZNTL | Zentalis Pharmaceuticals, Inc. | 285.85M | -13.15% | 2,368,582 | 26.87M |
| 292 | HELP | Cybin Inc. | 280.70M | 2.00% | 9,095,797 | - |
| 293 | CGEN | Compugen Ltd. | 272.32M | 2.13% | 274,648 | 72.76M |
| 294 | SABS | SAB Biotherapeutics, Inc. | 271.26M | 0.26% | 257,391 | 114.70K |
| 295 | PLYX | Polaryx Therapeutics, Inc. | 269.86M | -6.86% | 74,261 | - |
| 296 | ADAG | Adagene Inc. | 257.02M | -2.02% | 591,632 | 7.67M |
| 297 | OBIO | Orchestra BioMed Holdings, Inc. | 254.57M | -5.02% | 186,651 | 33.48M |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 252.97M | 0.56% | 288,522 | 82.03M |
| 299 | VYGR | Voyager Therapeutics, Inc. | 252.11M | 2.42% | 395,244 | 40.37M |
| 300 | MIST | Milestone Pharmaceuticals Inc. | 250.20M | -2.86% | 1,655,949 | 1.55M |
| 301 | NKTX | Nkarta, Inc. | 248.80M | 0.58% | 2,058,299 | - |
| 302 | CDXS | Codexis, Inc. | 238.08M | 1.16% | 1,039,064 | 70.39M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 234.16M | 0.45% | 70,536 | 3.50M |
| 304 | FENC | Fennec Pharmaceuticals Inc. | 232.02M | -0.88% | 68,978 | 44.64M |
| 305 | ALXO | ALX Oncology Holdings Inc. | 230.31M | 4.79% | 2,242,281 | - |
| 306 | KROS | Keros Therapeutics, Inc. | 229.91M | -0.09% | 225,794 | 244.06M |
| 307 | SLGL | Sol-Gel Technologies Ltd. | 228.83M | -5.24% | 26,391 | 19.39M |
| 308 | ACHV | Achieve Life Sciences, Inc. | 226.27M | -16.67% | 2,456,893 | - |
| 309 | ELTX | Elicio Therapeutics, Inc. | 224.43M | -9.96% | 146,807 | - |
| 310 | OABI | OmniAb, Inc. | 224.41M | -5.49% | 829,131 | 18.67M |
| 311 | MDWD | MediWound Ltd. | 222.99M | -2.09% | 26,742 | 16.96M |
| 312 | CRBU | Caribou Biosciences, Inc. | 221.30M | 4.09% | 1,965,577 | 11.16M |
| 313 | MGNX | MacroGenics, Inc. | 221.19M | 0.58% | 797,950 | 149.50M |
| 314 | NVCT | Nuvectis Pharma, Inc. | 220.68M | -6.40% | 31,954 | - |
| 315 | SGMT | Sagimet Biosciences Inc. | 209.85M | -0.46% | 427,362 | - |
| 316 | ENLV | Enlivex Ltd. | 207.92M | 1.91% | 393,269 | - |
| 317 | CNTX | Context Therapeutics Inc. | 207.65M | -7.00% | 993,394 | - |
| 318 | KRRO | Korro Bio, Inc. | 205.95M | -0.76% | 71,872 | 6.39M |
| 319 | ABOS | Acumen Pharmaceuticals, Inc. | 205.08M | 0.71% | 310,417 | - |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 203.71M | 2.58% | 311,926 | 13.11M |
| 321 | KPTI | Karyopharm Therapeutics Inc. | 201.54M | 3.83% | 185,814 | 146.07M |
| 322 | WHWK | Whitehawk Therapeutics, Inc. | 199.64M | 2.92% | 197,047 | 7.15M |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 198.86M | 2.33% | 320,045 | - |
| 324 | HRTX | Heron Therapeutics, Inc. | 197.96M | 5.00% | 1,356,436 | 154.90M |
| 325 | DTIL | Precision BioSciences, Inc. | 195.59M | -3.81% | 163,658 | 34.26M |
| 326 | PRQR | ProQR Therapeutics N.V. | 193.86M | -7.54% | 925,107 | 19.19M |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 188.36M | 0.28% | 318,786 | - |
| 328 | UNCY | Unicycive Therapeutics, Inc. | 187.52M | 5.84% | 901,798 | - |
| 329 | KALA | KALA BIO, Inc. | 185.90M | 0.55% | 1,947,538 | - |
| 330 | RNAC | Cartesian Therapeutics, Inc. | 183.97M | -1.42% | 150,672 | 2.80M |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 182.90M | -2.16% | 513,035 | 52.74M |
| 332 | HURA | TuHURA Biosciences, Inc. | 179.93M | -3.08% | 696,952 | - |
| 333 | MENS | Jyong Biotech Ltd. | 177.64M | -5.33% | 125,160 | - |
| 334 | BDTX | Black Diamond Therapeutics, Inc. | 174.73M | -0.33% | 693,318 | 70.00M |
| 335 | REPL | Replimune Group, Inc. | 170.93M | -4.61% | 4,661,251 | - |
| 336 | AGEN | Agenus Inc. | 169.72M | -7.72% | 1,305,058 | 114.20M |
| 337 | MOLN | Molecular Partners AG | 168.35M | 4.88% | 6,723 | 856.30K |
| 338 | SPRO | Spero Therapeutics, Inc. | 164.41M | 3.27% | 395,813 | 66.80M |
| 339 | FATE | Fate Therapeutics, Inc. | 161.61M | - | 1,334,518 | 6.65M |
| 340 | TNYA | Tenaya Therapeutics, Inc. | 160.88M | -5.20% | 2,300,933 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 154.91M | -1.29% | 151,375 | 2.00M |
| 342 | TLSA | Tiziana Life Sciences Ltd | 154.43M | -2.42% | 144,109 | - |
| 343 | HUMA | Humacyte, Inc. | 152.64M | -3.20% | 3,914,421 | 2.04M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 151.48M | -4.63% | 416,212 | 64.00K |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 151.33M | 4.43% | 96,187 | - |
| 346 | GALT | Galectin Therapeutics Inc. | 150.74M | -6.53% | 402,435 | - |
| 347 | ACOG | Alpha Cognition Inc. | 150.02M | -0.72% | 55,761 | 10.22M |
| 348 | BMEA | Biomea Fusion, Inc. | 148.21M | -7.24% | 1,718,682 | - |
| 349 | IPHA | Innate Pharma S.A. | 143.68M | -4.22% | 13,777 | 10.57M |
| 350 | ANTX | AN2 Therapeutics, Inc. | 130.27M | 0.28% | 151,655 | - |
| 351 | ONCY | Oncolytics Biotech Inc. | 128.90M | -0.89% | 790,130 | - |
| 352 | NTHI | NeOnc Technologies Holdings, Inc. | 128.67M | -3.28% | 32,207 | 39.99K |
| 353 | VANI | Vivani Medical, Inc. | 127.82M | 12.69% | 954,719 | - |
| 354 | EQ | Equillium, Inc. | 127.09M | -1.95% | 667,076 | 4.39M |
| 355 | IMUX | Immunic, Inc. | 124.59M | -4.50% | 5,910,731 | - |
| 356 | AARD | Aardvark Therapeutics, Inc. | 123.26M | 8.03% | 253,146 | - |
| 357 | CRDF | Cardiff Oncology, Inc. | 121.69M | -1.11% | 713,702 | 593.00K |
| 358 | IFRX | InflaRx N.V. | 120.01M | 4.40% | 1,355,108 | 34.44K |
| 359 | KZIA | Kazia Therapeutics Limited | 119.87M | -5.50% | 262,856 | 1.27M |
| 360 | PEPG | PepGen Inc. | 119.57M | 1.76% | 924,637 | - |
| 361 | CBUS | Cibus, Inc. | 118.83M | -1.89% | 382,816 | 3.64M |
| 362 | GNLX | Genelux Corporation | 117.59M | -5.02% | 127,497 | 8.00K |
| 363 | COYA | Coya Therapeutics, Inc. | 117.05M | 4.39% | 234,825 | 7.95M |
| 364 | SEER | Seer, Inc. | 112.28M | -0.50% | 335,344 | 16.58M |
| 365 | SGMO | Sangamo Therapeutics, Inc. | 111.90M | 3.09% | 4,946,442 | 39.55M |
| 366 | VRCA | Verrica Pharmaceuticals Inc. | 109.60M | 0.95% | 74,554 | 35.58M |
| 367 | ALDX | Aldeyra Therapeutics, Inc. | 107.13M | -1.11% | 980,795 | - |
| 368 | PYXS | Pyxis Oncology, Inc. | 106.81M | 2.41% | 239,697 | 13.86M |
| 369 | NRXP | NRx Pharmaceuticals, Inc. | 105.71M | 25.49% | 4,499,431 | 1.23M |
| 370 | PMN | ProMIS Neurosciences, Inc. | 102.64M | -0.74% | 58,860 | - |
| 371 | TTRX | Turn Therapeutics Inc. | 100.68M | -2.31% | 16,721 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 100.58M | 3.09% | 132,905 | - |
| 373 | CGTX | Cognition Therapeutics, Inc. | 100.08M | -5.88% | 1,034,125 | - |
| 374 | GOSS | Gossamer Bio, Inc. | 98.57M | -5.83% | 4,577,084 | 48.47M |
| 375 | QTTB | Q32 Bio Inc. | 97.29M | 13.68% | 956,207 | 53.74M |
| 376 | RANI | Rani Therapeutics Holdings, Inc. | 97.10M | 1.81% | 777,291 | 1.63M |
| 377 | COEP | Coeptis Therapeutics Holdings, Inc. | 96.71M | 6.08% | 162,999 | 1.36M |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 96.69M | -0.84% | 1,972,449 | 65.34K |
| 379 | SPRB | Spruce Biosciences, Inc. | 95.92M | -0.58% | 70,423 | 697.00K |
| 380 | ACET | Adicet Bio, Inc. | 93.20M | 5.47% | 131,552 | - |
| 381 | GUTS | Fractyl Health, Inc. | 91.30M | 1.07% | 1,354,095 | 3.00K |
| 382 | EXOZ | eXoZymes, Inc. | 90.39M | 0.57% | 6,269 | -700.00 |
| 383 | GANX | Gain Therapeutics, Inc. | 89.55M | -0.47% | 524,992 | - |
| 384 | PYPD | PolyPid Ltd. | 89.50M | -1.05% | 63,629 | - |
| 385 | LONA | LeonaBio, Inc. | 88.11M | 5.87% | 65,952 | - |
| 386 | TCRX | TScan Therapeutics, Inc. | 85.94M | 20.17% | 2,890,911 | 10.33M |
| 387 | ATHE | Alterity Therapeutics Limited | 85.80M | 15.21% | 120,197 | 4.43M |
| 388 | MCRB | Seres Therapeutics, Inc. | 85.70M | 0.56% | 22,111 | 789.00K |
| 389 | MAIA | MAIA Biotechnology, Inc. | 85.55M | 4.44% | 661,364 | - |
| 390 | FLNA | Filana Therapeutics, Inc. | 84.54M | 1.16% | 309,891 | - |
| 391 | CSBR | Champions Oncology, Inc. | 84.36M | 0.58% | 4,142 | 57.95M |
| 392 | ATYR | aTyr Pharma, Inc. | 83.66M | -0.02% | 850,371 | 190.00K |
| 393 | OKYO | OKYO Pharma Limited | 83.44M | -4.22% | 82,034 | - |
| 394 | CUE | Cue Biopharma, Inc. | 82.97M | 40.15% | 19,700,832 | 27.47M |
| 395 | PLRX | Pliant Therapeutics, Inc. | 79.87M | -3.01% | 2,323,205 | - |
| 396 | NRXS | NeurAxis, Inc. | 78.31M | -3.05% | 141,903 | 3.57M |
| 397 | ESLA | Estrella Immunopharma, Inc. | 77.22M | -3.72% | 21,479 | - |
| 398 | IMMP | Immutep Limited | 77.16M | 5.58% | 13,642,688 | 5.28M |
| 399 | PTHS | Pelthos Therapeutics Inc. | 77.01M | -0.30% | 13,921 | 16.80M |
| 400 | XBIT | XBiotech Inc. | 76.52M | 2.03% | 46,140 | - |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 76.26M | 3.62% | 201,705 | - |
| 402 | FBIO | Fortress Biotech, Inc. | 74.71M | -1.69% | 225,413 | 63.26M |
| 403 | IBO | Impact BioMedical Inc. | 73.32M | 5.43% | 289,574 | 32.00K |
| 404 | BYSI | BeyondSpring Inc. | 73.00M | 2.62% | 8,141 | 1.88M |
| 405 | ICCC | ImmuCell Corporation | 72.56M | 0.50% | 20,222 | 27.64M |
| 406 | MNOV | MediciNova, Inc. | 72.36M | 0.68% | 5,729 | 409.66K |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 72.06M | 4.49% | 1,199,613 | - |
| 408 | PDSB | PDS Biotechnology Corporation | 72.00M | -1.53% | 711,584 | - |
| 409 | GRCE | Grace Therapeutics, Inc. | 71.03M | -0.22% | 1,074,438 | - |
| 410 | CING | Cingulate Inc. | 70.12M | 10.64% | 574,024 | - |
| 411 | OKUR | OnKure Therapeutics, Inc. | 68.23M | -0.20% | 69,684 | - |
| 412 | IBIO | iBio, Inc. | 68.05M | -4.37% | 888,930 | 300.00K |
| 413 | IMA | ImageneBio, Inc. | 67.11M | 1.69% | 39,643 | 800.00K |
| 414 | ANVS | Annovis Bio, Inc. | 66.30M | 2.67% | 903,519 | - |
| 415 | INKT | MiNK Therapeutics, Inc. | 63.66M | -9.78% | 91,017 | - |
| 416 | HYFT | MindWalk Holdings Corp. | 63.08M | -4.51% | 128,489 | 20.70M |
| 417 | ENTX | Entera Bio Ltd. | 62.47M | 4.69% | 235,213 | 42.00K |
| 418 | ACTU | Actuate Therapeutics, Inc. | 62.12M | 13.42% | 1,011,466 | - |
| 419 | EDSA | Edesa Biotech, Inc. | 59.98M | 13.83% | 425,075 | - |
| 420 | OSTX | OS Therapies Incorporated | 58.01M | -0.72% | 641,635 | - |
| 421 | MGX | Metagenomi Therapeutics, Inc. | 57.56M | 3.38% | 356,214 | 25.21M |
| 422 | TIL | Instil Bio, Inc. | 56.90M | -5.52% | 17,495 | - |
| 423 | KZR | Kezar Life Sciences, Inc. | 53.86M | -0.55% | 151,703 | - |
| 424 | MREO | Mereo BioPharma Group plc | 53.79M | 0.12% | 1,066,442 | 500.00K |
| 425 | DWTX | Dogwood Therapeutics, Inc. | 53.44M | -3.61% | 59,195 | - |
| 426 | RADX | Radiopharm Theranostics Limited | 53.38M | 4.59% | 59,064 | 10.86M |
| 427 | ATOS | Atossa Therapeutics, Inc. | 53.13M | 5.83% | 127,941 | - |
| 428 | RNTX | Rein Therapeutics Inc. | 51.31M | 3.98% | 100,315 | - |
| 429 | NTRB | Nutriband Inc. | 51.06M | -2.33% | 5,979 | 2.28M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 50.88M | 2.07% | 201,861 | - |
| 431 | PSTV | Plus Therapeutics, Inc. | 50.09M | 14.24% | 694,255 | 5.21M |
| 432 | XLO | Xilio Therapeutics, Inc. | 48.86M | -1.40% | 68,335 | 43.77M |
| 433 | HYPD | Hyperion DeFi, Inc. | 48.76M | -4.04% | 658,775 | 813.46K |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 47.12M | 2.54% | 303,552 | 1.14M |
| 435 | RNXT | RenovoRx, Inc. | 45.28M | 0.50% | 205,772 | 1.12M |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 44.89M | 10.77% | 744,384 | 90.00K |
| 437 | RLYB | Rallybio Corporation | 43.85M | 0.85% | 20,580 | 858.00K |
| 438 | LITS | Lite Strategy, Inc. | 43.27M | 0.85% | 256,548 | - |
| 439 | SNSE | Sensei Biotherapeutics, Inc. | 42.07M | 2.95% | 64,971 | - |
| 440 | DARE | Daré Bioscience, Inc. | 41.79M | -2.71% | 1,067,879 | 1.03M |
| 441 | NXTC | NextCure, Inc. | 41.66M | 13.26% | 158,368 | - |
| 442 | ATRA | Atara Biotherapeutics, Inc. | 40.81M | -5.31% | 82,225 | 120.77M |
| 443 | ALGS | Aligos Therapeutics, Inc. | 40.28M | -2.54% | 243,266 | 2.19M |
| 444 | LIXT | Lixte Biotechnology Holdings, Inc. | 39.91M | -4.85% | 7,821 | - |
| 445 | INMB | INmune Bio Inc. | 39.61M | 2.76% | 181,727 | 50.00K |
| 446 | PTN | Palatin Technologies, Inc. | 39.18M | -1.91% | 21,300 | 8.96M |
| 447 | VERU | Veru Inc. | 39.00M | -0.41% | 83,308 | 16.89M |
| 448 | OTLK | Outlook Therapeutics, Inc. | 38.71M | 19.66% | 8,918,210 | 205.70K |
| 449 | EVAX | Evaxion A/S | 37.45M | 0.90% | 60,140 | 7.53M |
| 450 | CRVO | CervoMed Inc. | 36.76M | -0.25% | 40,866 | 4.01M |
| 451 | PLUR | Pluri Inc. | 36.08M | -0.83% | 639 | 1.34M |
| 452 | BOLD | Boundless Bio, Inc. | 35.85M | 1.27% | 188,691 | - |
| 453 | CELU | Celularity Inc. | 35.76M | 0.81% | 28,780 | 40.58M |
| 454 | SNTI | Senti Biosciences, Inc. | 35.50M | 3.64% | 490,141 | 22.00K |
| 455 | TVGN | Tevogen Bio Holdings Inc. | 34.56M | 12.47% | 38,665 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 32.12M | -1.52% | 65,303 | 797.92K |
| 457 | DYAI | Dyadic International, Inc. | 32.03M | 0.46% | 7,806 | 3.09M |
| 458 | CVM | CEL-SCI Corporation | 31.89M | -20.40% | 205,283 | - |
| 459 | LTRN | Lantern Pharma Inc. | 30.94M | 10.84% | 238,167 | - |
| 460 | IGC | IGC Pharma, Inc. | 30.57M | -5.03% | 35,910,431 | 1.11M |
| 461 | LGVN | Longeveron Inc. | 30.45M | -5.45% | 1,121,004 | 1.20M |
| 462 | TVRD | Tvardi Therapeutics, Inc. | 30.21M | -5.01% | 29,487 | - |
| 463 | KYNB | Kyntra Bio, Inc. | 29.70M | 0.27% | 3,884 | 6.44M |
| 464 | JSPR | Jasper Therapeutics, Inc. | 29.68M | 3.92% | 640,718 | - |
| 465 | BCTX | BriaCell Therapeutics Corp. | 29.16M | -9.26% | 399,754 | - |
| 466 | APLM | Apollomics, Inc. | 29.05M | -2.66% | 640 | 6.93M |
| 467 | MRKR | Marker Therapeutics, Inc. | 27.84M | 0.60% | 57,950 | 3.55M |
| 468 | TPST | Tempest Therapeutics, Inc. | 27.83M | -1.02% | 128,026 | - |
| 469 | NNVC | NanoViricides, Inc. | 27.64M | -6.57% | 502,945 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 27.12M | 5.45% | 50,222 | 14.99M |
| 471 | AEON | AEON Biopharma, Inc. | 27.07M | 4.90% | 187,335 | - |
| 472 | SKYE | Skye Bioscience, Inc. | 26.15M | -0.70% | 114,831 | - |
| 473 | PBM | Psyence Biomedical Ltd. | 25.91M | 48.68% | 41,951,887 | - |
| 474 | SER | Serina Therapeutics, Inc. | 25.86M | 2.44% | 52,826 | 130.00K |
| 475 | LSTA | Lisata Therapeutics, Inc. | 25.56M | -12.38% | 119,077 | 170.00K |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 25.10M | 0.42% | 148,465 | - |
| 477 | CRIS | Curis, Inc. | 24.66M | 2.31% | 490,848 | 9.44M |
| 478 | LEXX | Lexaria Bioscience Corp. | 24.64M | -3.50% | 190,624 | 368.00K |
| 479 | VTGN | Vistagen Therapeutics, Inc. | 24.12M | -3.03% | 602,986 | 789.00K |
| 480 | BRNS | Barinthus Biotherapeutics plc | 24.10M | - | 36,338 | 14.97M |
| 481 | XCUR | Exicure, Inc. | 24.02M | -0.53% | 8,359 | 500.00K |
| 482 | TRAW | Traws Pharma, Inc. | 22.43M | 11.20% | 331,627 | 2.79M |
| 483 | VYNE | VYNE Therapeutics Inc. | 21.10M | 3.79% | 441,517 | 570.00K |
| 484 | COCP | Cocrystal Pharma, Inc. | 20.82M | - | 185,116 | - |
| 485 | PLRZ | Polyrizon Ltd. | 20.75M | 2.02% | 36,805 | - |
| 486 | QNCX | Quince Therapeutics, Inc. | 20.70M | -7.30% | 1,747,252 | - |
| 487 | PASG | Passage Bio, Inc. | 20.05M | -46.44% | 1,220,964 | - |
| 488 | OSRH | OSR Holdings, Inc. | 19.87M | 5.26% | 435,871 | 2.91M |
| 489 | ALLR | Allarity Therapeutics, Inc. | 19.77M | 1.63% | 104,081 | 320.00K |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 19.56M | 1.85% | 389,342 | 3.94M |
| 491 | TOVX | Theriva Biologics, Inc. | 18.82M | 59.41% | 648,627,828 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 18.49M | 10.24% | 99,734 | 1.23M |
| 493 | QNTM | Quantum BioPharma Ltd. | 17.94M | - | 77,523 | - |
| 494 | KTTA | Pasithea Therapeutics Corp. | 17.89M | -3.38% | 1,964,439 | - |
| 495 | LPCN | Lipocine Inc. | 16.79M | -5.35% | 425,538 | 1.98M |
| 496 | JUNS | Jupiter Neurosciences, Inc. | 16.69M | 5.22% | 49,624 | 21.80K |
| 497 | GNTA | Genenta Science S.p.A. | 16.53M | -3.99% | 50,133 | - |
| 498 | HIND | Vyome Holdings, Inc. | 16.49M | 6.33% | 24,266 | 319.71K |
| 499 | CDT | CDT Equity Inc. | 16.30M | -3.03% | 48,485 | - |
| 500 | INAB | IN8bio, Inc. | 14.77M | 4.17% | 76,847 | - |